Skip to Content

Clorox Co

CLX: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$754.00JklxTzxyrgttxj

Its Long-Term Bent Should Enable Clorox's Competitive Edge to Withstand Inflation's Fury

Business Strategy and Outlook

The pandemic prompted consumers to scour the shelves for Clorox's fare, boosting sales. And even as volume growth is decelerating, we don’t think consumers are turning their backs on Clorox’s cleaning and disinfecting products, as sales remain well above where they were before the pandemic (to the tune of 5% in its fiscal fourth quarter). This prowess is further evidenced by its disinfecting wipes offering, which posted its fourth-consecutive quarter of market share gains.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of CLX so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center